1994
DOI: 10.1093/infdis/170.5.1296
|View full text |Cite
|
Sign up to set email alerts
|

Occurrence Of Human Immunodeficiency Virus Type I (HIV-I)-Specific Cytolytic T Cell Activity In Apparently Uninfected Children Born To HIV-1-Infected Mothers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
61
0

Year Published

1996
1996
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 134 publications
(64 citation statements)
references
References 0 publications
3
61
0
Order By: Relevance
“…Previous studies by our group and others in perinatal HIV-exposed infants have reported evidence of HIV-specific immune response (4,(18)(19)(20)(21)(22)(23)(24)(25). HIV-specific immune response has also been observed in exposed noninfected adults (26)(27)(28)(29).…”
Section: Discussionsupporting
confidence: 53%
“…Previous studies by our group and others in perinatal HIV-exposed infants have reported evidence of HIV-specific immune response (4,(18)(19)(20)(21)(22)(23)(24)(25). HIV-specific immune response has also been observed in exposed noninfected adults (26)(27)(28)(29).…”
Section: Discussionsupporting
confidence: 53%
“…Those studies suggest that ␤-chemokines are synthesized by normal CD8 ϩ T cells that have a CTL effector phenotype. Thus, it is possible that ␤-chemokines contribute to the correlations between CTL and the reduction of viral loads (14)(15)(16)(17)(18) or protection against infection with HIV-1 (19)(20)(21)(22).…”
mentioning
confidence: 99%
“…There are also some individuals who remain seronegative despite high risk and/or multiple exposures to HIV-1. These exposed seronegatives (ES) include infants born to HIV-1 infected mothers [5][6][7], commercial sex workers in epidemic areas [8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25], hemophiliacs who received HIV contaminated factor VIII preparations [26,27], and sexual partners of known HIV-1 infected persons [28][29][30][31][32][33]. Understanding the mechanisms that account for slower disease progression in LTNP and the protection against HIV-1 infection observed with ES is important for the development of more potent therapeutic regimens and a vaccine.…”
Section: Introductionmentioning
confidence: 99%